A. Michael Lincoff, M.D.
Director, Cleveland Clinic Cardiovascular Coordinating Center
Professor of Medicine,
Cleveland Clinic, Lerner College of Medicine of Case Western Reserve University
PCI-LANDMARK TRIALS
1. ACUITY TRIAL-ACS Landmark Trial
2. REPLACE-2 Trial (30-day Results)
1. The CACHET Trial: Bilvalirudin With
Planned or Provisional Abciximab
1. Bleeding Severity: Impact on Clinical Outcomes in ACS Patients
1. ACC/AHA/SCAI Guidelines for PCI
2. ACCP PCI Guidelines
For more information, go to
www.clinicalwebcasts.com